Hologic, Inc. - Common Stock (HOLX)
63.27
-0.12 (-0.19%)
Hologic Inc. is a global medical technology company focused on improving women's health through the development and delivery of innovative products and solutions
The company specializes in diagnostic, surgical, and medical imaging systems, with a particular emphasis on breast health, cervical health, and skeletal health. Hologic's offerings include advanced molecular diagnostics, imaging systems for breast cancer detection, and various surgical instruments and techniques that enhance patient care. With a commitment to advancing health outcomes for women, Hologic actively invests in research and development to address unmet medical needs and improve access to vital healthcare solutions.

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the Raymond James & Associates' 46th Annual Institutional Investors Conference on Tuesday, March 4 at 11 a.m. Eastern Time (ET).
By Hologic, Inc. · Via Business Wire · February 25, 2025

Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Aptima® SARS-CoV-2 assay, which was first granted Emergency Use Authorization (EUA) status in May 2020.
By Hologic, Inc. · Via Business Wire · February 18, 2025

Hologic, Inc. (Nasdaq: HOLX) announced today the Company’s financial results for the fiscal first quarter ended December 28, 2024.
By Hologic, Inc. · Via Business Wire · February 5, 2025

Women’s cancer testing has declined globally, according to the latest Hologic Global Women’s Health Index, one of the largest collections of data on women’s health and well-being.
By Hologic, Inc. · Via Business Wire · January 21, 2025

Hologic, Inc. (Nasdaq: HOLX) announced today preliminary revenue results for its first fiscal quarter ended December 28, 2024.
By Hologic, Inc. · Via Business Wire · January 12, 2025

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 1:30 p.m. Pacific Time.
By Hologic, Inc. · Via Business Wire · January 7, 2025

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the first quarter of fiscal 2025 on Wednesday, February 5, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.
By Hologic, Inc. · Via Business Wire · January 6, 2025

Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, has completed its previously announced acquisition of Gynesonics, Inc. (Gynesonics®), a privately held medical device company focused on the development of minimally invasive solutions for women’s health, for approximately $350 million.
By Hologic, Inc. · Via Business Wire · January 6, 2025

Hologic, Inc. (Nasdaq: HOLX) today announced that it has entered into an agreement with the Centers for Disease Control and Prevention (CDC) to develop analyte specific reagents (ASRs) — the “active ingredients” of laboratory-developed tests used to identify specific diseases or conditions — that would aid in the detection of H5N1 bird flu.
By Hologic, Inc. · Via Business Wire · December 18, 2024

Hologic, Inc., (Nasdaq: HOLX) a global leader in women’s health focused on developing innovative medical technologies that effectively detect, diagnose and treat health conditions, today issued the following statement regarding the United States Preventive Services Task Force draft guidelines for cervical cancer screening:
By Hologic, Inc. · Via Business Wire · December 10, 2024

Hologic, Inc. (Nasdaq: HOLX) announced today that Martin Madaus has been elected to the Company’s Board of Directors, effective December 6, 2024. Dr. Madaus was also appointed to the Compensation Committee and the Nominating and Corporate Governance Committee effective December 6, 2024.
By Hologic, Inc. · Via Business Wire · December 9, 2024

Four new studies regarding the Breast Cancer Index (BCI) test will be presented at the 2024 San Antonio Breast Cancer Symposium (SABCS). Among these studies, initial data will be premiered investigating the potential role of the BCI test to identify postmenopausal women with hormone-receptor positive (HR+), early-stage, node-negative disease who are at minimal risk of experiencing a distant recurrence. Full results will be shared during Poster Session 1 on December 11, 2024, at 12:30 p.m. CT [#P1-09-13].
By Hologic, Inc. · Via Business Wire · December 9, 2024

Hologic, Inc. (Nasdaq: HOLX) yesterday presented new research demonstrating the performance of its Genius AI® Detection 2.0 software across diverse patient populations at the 110th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA).
By Hologic, Inc. · Via Business Wire · December 2, 2024

Hologic, Inc. (Nasdaq: HOLX) will reveal new technologies reimagining the future of breast health at the 110th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago on December 1-5. On the show floor and during multiple workshops, Hologic will showcase AI-powered breast imaging advancements designed to assess breast density, enhance workflows and improve cancer detection.
By Hologic, Inc. · Via Business Wire · November 25, 2024

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the following upcoming investor conferences:
By Hologic, Inc. · Via Business Wire · November 14, 2024

Hologic, Inc. (Nasdaq: HOLX) announced today the Company’s financial results for the fiscal fourth quarter ended September 28, 2024.
By Hologic, Inc. · Via Business Wire · November 4, 2024

Hologic, Inc. (Nasdaq: HOLX), a global champion of women’s health, today announced that it has signed a definitive agreement to acquire Gynesonics, Inc. (Gynesonics®), a privately held medical device company focused on the development of minimally invasive solutions for women’s health for approximately $350 million, subject to working capital and other customary closing adjustments.
By Hologic, Inc. · Via Business Wire · October 14, 2024

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the fourth quarter of fiscal 2024 on Monday, November 4, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.
By Hologic, Inc. · Via Business Wire · October 4, 2024

Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, will kick off Breast Cancer Awareness Month by ringing the Nasdaq opening bell for the 18th year. As part of this annual tradition, Hologic is launching a comprehensive patient education campaign to bust common myths about breast cancer, mammograms and breast density.
By Hologic, Inc. · Via Business Wire · September 30, 2024

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the Morgan Stanley 22nd Annual Global Healthcare Conference in New York on Thursday, September 5th, at 12:20 p.m. Eastern Time.
By Hologic, Inc. · Via Business Wire · August 29, 2024

Hologic, Inc. (Nasdaq: HOLX) announced today the Company’s financial results for the fiscal third quarter ended June 29, 2024.
By Hologic, Inc. · Via Business Wire · July 29, 2024

Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, has completed its previously announced acquisition of Endomagnetics Ltd (Endomag), a privately held UK-based developer of breast cancer surgery technologies, for approximately $310 million.
By Hologic, Inc. · Via Business Wire · July 25, 2024

Millions of women in the United States have missed screenings for serious, often life-threatening conditions, according to a new survey released today by women’s health innovator Hologic, Inc. (Nasdaq: HOLX).
By Hologic, Inc. · Via Business Wire · July 9, 2024

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the third quarter of fiscal 2024 on Monday, July 29, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.
By Hologic, Inc. · Via Business Wire · July 2, 2024

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the following upcoming investor conferences:
By Hologic, Inc. · Via Business Wire · May 21, 2024